Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax
Researchers describe findings in anthrax studies
August 15th, 2005
Anthrax research advances have been reported from the United States. Study 1: An edema factor-mediated cAMP-induction bioassay detects antibody-mediated neutralization of anthrax protective antigen. According to a study from the United States, "Intoxication of mammalian cells by Bacillus anthracis requires the coordinate activity of three distinct bacterial proteins: protective antigen (PA), edema factor (EF), and lethal factor (LF). "Among these proteins, PA has become the major focus of work on monoclonal antibodies and vaccines designed to treat or prevent anthrax infection since neither EF nor LF is capable of inducing...
Source: Pharma Business Week (2005-08-15)
|
